Login / Signup
Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up.
Anne M Horne
Borislav Mihov
Ian R Reid
Published in:
Calcified tissue international (2019)
Keyphrases
</>
bone loss
bone mineral density
giant cell
postmenopausal women
body composition